美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Dorsey Wright Healthcare Momentum ETF

61.14

-0.8805-1.42%

盤後：61.170.0281+0.05%19:30 EDT

成交量：2.15萬

成交額：131.52萬

市值：2.87億

市盈率：20.00

高：62.20

開：62.20

低：60.99

收：62.02

52周最高：64.10

52周最低：40.28

股本：470.00萬

流通股本：470.00萬

量比：0.44

換手率：0.46%

股息：1.53

股息率：2.50%

每股收益(TTM):3.06

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Revolution Medicines的胰腺癌藥物 Daraxonrasib已獲得美國監管機構的批准，這是首款針對胰腺

《JAMA皮膚病學》發布Brepocitinib治療皮肌炎3期VALOR試驗皮膚特異性結果

美國食品藥品監督管理局（FDA）批准了Revolution Medicines公司的一款胰腺癌藥物

江蘇：推動相關縣聚焦創新藥和高端醫療器械等產業，建立「N個1」培育機制，因地制宜發展特色優勢產業

江蘇：加快培育一批研發創新能力強、國際化水平高的世界一流製藥集團與醫療器械領軍企業

採納股份：全資子公司取得一次性使用人體動脈血樣採集器醫療器械註冊證

三力製藥在陝西成立藥品銷售新公司

康拓醫療：控股子公司取得第三類醫療器械註冊證

步長製藥等成立新公司註冊資本5000萬元

【券商聚焦】中信建投：醫療器械板塊估值正在重構

美國法院在DNA測序專利糾紛案中裁定Guardant公司支付2.45億美元

Twinstrand：法院判決公司及Uw獲賠逾2.452億美元，涵蓋截至2026年5月31日的侵權損害賠償、應計特許權使用費及利息

Twinstrand勝訴：法院維持2023年故意侵權判決，並裁定Guardant Health 11項產品與服務須支付6%特許權使用費

Twinstrand案判決：Guardant Health須按季度向公司及承銷商彙報11款產品與服務的全美銷售明細

Twinstrand：特拉華州法院於8月21日裁定公司及華盛頓大學在針對Guardant Health的專利侵權訴訟中勝訴

印度提議修改醫療器械規則。

新產業：獲得血管緊張素轉化酶測定試劑盒醫療器械註冊證

萬孚生物：取得7項化學發光類醫療器械註冊證

翔宇醫療激光毫米波治療儀獲國家醫療器械註冊證

貴州公布13起典型案例

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/PTH/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":61.1419,"timestamp":1789761600000,"preClose":62.0224,"halted":0,"volume":21465,"hourTrading":{"tag":"盘后","latestPrice":61.17,"preClose":61.1419,"latestTime":"19:30 EDT","volume":14,"amount":854.6914,"timestamp":1789774205841,"change":0.0281,"changeRate":0.00046,"amplitude":0},"delay":0,"changeRate":-0.014196483850995735,"floatShares":4700000,"shares":4700000,"eps":3.057033,"marketStatus":"休市中","change":-0.8805,"latestTime":"09-18 16:00:00 EDT","open":62.1967,"high":62.1967,"low":60.985,"amount":1315202.557005,"amplitude":0.019536,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.0224,"sharesOutstanding":2480000,"nav":61.98522,"aum":293809942.8,"dividendRate":0.024953,"bidAskSpread":0.001708,"preHourTrading":{"tag":"盘前","latestPrice":62.0224,"preClose":62.0224,"latestTime":"04:00 EDT","volume":1,"amount":62.0224,"timestamp":1789718420500,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":61.17,"preClose":61.1419,"latestTime":"19:30 EDT","volume":14,"amount":854.6914,"timestamp":1789774205841,"change":0.0281,"changeRate":0.00046,"amplitude":0},"volumeRatio":0.44234201260746575,"impliedVol":0.0872,"impliedVolPercentile":0.243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4700000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.44234201260746575,"shares":4700000,"dividePrice":1.5257,"high":62.1967,"amplitude":0.019536,"preClose":62.0224,"low":60.985,"week52Low":40.28,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":61.1419,"eps":3.057033,"divideRate":0.024953,"volume":21465,"delay":0,"ttmEps":3.057033,"open":62.1967,"prevYearClose":49.701,"prevWeekClose":60.7692,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":60.7692,"twentyDayClose":62.111,"sixtyDayClose":55.6532},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662482997","title":"Revolution Medicines的胰腺癌藥物 Daraxonrasib已獲得美國監管機構的批准，這是首款針對胰腺","url":"https://stock-news.laohu8.com/highlight/detail?id=2662482997","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662482997?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:14","pubTimestamp":1787757271,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","BK4139","IE0009354923.USD","LU0109394709.USD","IE0002141913.USD","RVMD","BBH","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","PTH","IE00B2B36J28.USD","LU0320765992.SGD","LU0889565916.HKD","IDNA","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169456208","title":"《JAMA皮膚病學》發布Brepocitinib治療皮肌炎3期VALOR試驗皮膚特異性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1169456208","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169456208?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:12","pubTimestamp":1787757130,"startTime":"0","endTime":"0","summary":"《JAMA皮肤病学》杂志正式刊发了Brepocitinib在皮肌炎治疗中的3期VALOR试验皮肤特异性结局数据。这项研究聚焦于皮肤相关症状的改善情况，为这一罕见自身免疫性疾病的治疗提供了新的临床证据。该试验结果此前已引起业界广泛关注，如今皮肤特异性数据的公布，进一步丰富了人们对Brepocitinib疗效维度的理解。皮肌炎以皮肤和肌肉炎症为特征，皮肤表现往往对患者生活质量造成显著影响，因此这一数据的发布具有重要临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PTH","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662271008","title":"美國食品藥品監督管理局（FDA）批准了Revolution Medicines公司的一款胰腺癌藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2662271008","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662271008?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 22:44","pubTimestamp":1787755452,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准了Revolution Medicines公司的一款胰腺癌药物路透8月26日-美国食品药品监督管理局周三表示，已批准Revolution Medicines公司用于治疗转移性胰腺癌的靶向药物RVMD.O。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4T44N176:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IDNA","RVMD","LU0109394709.USD","PTH","BBH","IE0009354923.USD","IE0009355771.USD","LU0320765992.SGD","BK4139","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662471794","title":"江蘇：推動相關縣聚焦創新藥和高端醫療器械等產業，建立「N個1」培育機制，因地制宜發展特色優勢產業","url":"https://stock-news.laohu8.com/highlight/detail?id=2662471794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662471794?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:43","pubTimestamp":1787737421,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","GDOC","LGHT","MDEV","AGNG","IEIH","RSPH","MEDX","PTH","IBBQ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662779444","title":"江蘇：加快培育一批研發創新能力強、國際化水平高的世界一流製藥集團與醫療器械領軍企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2662779444","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662779444?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:43","pubTimestamp":1787737395,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","LNGR","HART","MEDX","PTH","IEIH","AGNG","RSPH","GDOC","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795505","title":"採納股份：全資子公司取得一次性使用人體動脈血樣採集器醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795505?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 15:59","pubTimestamp":1787731173,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","LGHT","RSPH","HART","MDEV","PTH","MEDX","GDOC","LNGR","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276595","title":"三力製藥在陝西成立藥品銷售新公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276595?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 08:53","pubTimestamp":1787705590,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","LGHT","GDOC","MDEV","AGNG","IEIH","RSPH","MEDX","PTH","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808847","title":"康拓醫療：控股子公司取得第三類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808847","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808847?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 17:13","pubTimestamp":1787649205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","IEIH","AGNG","GDOC","HART","MEDX","PTH","RSPH","LGHT","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662788168","title":"步長製藥等成立新公司 註冊資本5000萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662788168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662788168?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 11:09","pubTimestamp":1787627361,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","LNGR","MEDX","MDEV","PTH","IEIH","LGHT","HART","GDOC","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705207","title":"【券商聚焦】中信建投：醫療器械板塊估值正在重構","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705207","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705207?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:32","pubTimestamp":1787621521,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，建议2026年加配医疗器械板块，短期来看，建议把握2026年业绩改善个股的业绩和估值修复机会，高值耗材和IVD板块的集采或降价影响将于下半年逐步出清，多家细分赛道龙头将于2026年迎来加速增长，同时建议关注手术机器人、脑机接口等新科技方向，相关技术突破和商业化落地有望持续催化板块热度。长期来看，医疗器械板块投资机会来自创新、出海和并购整合，板块的创新和国际化能力得到认可，估值正在重构。风险提示：行业政策风险、研发不及预期风险、审批不及预期风险、宏观环境波动风险、中东地缘政治风险。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","BK1502","BK1587","BK1610","HART","BK1100","PTH","LU0287142896.SGD","LNGR","BK1161","BK1515","BK1617","BK1615","BK1584","159883","BK1591","KCE","02252","LGHT","BK1222","BK1600","GDOC","BK1247","BK0276","BK1571","BK1189","IEIH","MEDX","BK1593","LU0173614495.USD","BK1142","BK1585","BK1589","02190","00853","MDEV","BK1583","01302","BK1501","BK1574","HK0000165453.HKD","02235","601066","09996","00241","01066","06826","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661227372","title":"美國法院在DNA測序專利糾紛案中裁定Guardant公司支付2.45億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661227372","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661227372?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:21","pubTimestamp":1787570491,"startTime":"0","endTime":"0","summary":"美国法院在DNA测序专利纠纷案中裁定Guardant公司支付2.45亿美元路透8月24日-TwinStrand Biosciences周一表示，美国一家法院裁定Guardant Health公司侵犯了涉及DNA测序技术的专利，并责令其向TwinStrand Biosciences和华盛顿大学支付超过2.452亿美元的赔偿金。法院裁定，Guardant必须就其11项被认定侵犯专利的产品及服务在美国的销售额，支付6%的专利使用费，直至2033年3月相关专利到期为止。TwinStrand表示，该判决所涵盖的产品和服务约占Guardant在侵权期间总收入的90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4T44L0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4588","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4585","EKG","GDOC","GNOM","BK4551","PTH","BK4196","BK4535","LFSC","FFOX","HELX","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160211496","title":"Twinstrand：法院判決公司及Uw獲賠逾2.452億美元，涵蓋截至2026年5月31日的侵權損害賠償、應計特許權使用費及利息","url":"https://stock-news.laohu8.com/highlight/detail?id=1160211496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160211496?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:01","pubTimestamp":1787569302,"startTime":"0","endTime":"0","summary":"Twinstrand公告，法院已作出裁决，判令公司及Uw获得超过2.452亿美元的赔偿金。这笔款项涵盖了截至2026年5月31日期间所发生的侵权损害、累积的特许权使用费以及相应利息。\n裁决金额之巨，彰显了司法体系对知识产权保护的坚定立场。赔偿总额精确计算至该截止日期，包括了多层次的补偿要素。侵权行为的认定范围，则明确划定在2026年5月31日之前发生的全部相关行为。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU0889565916.HKD","BK4196","GH","LFSC","GNMX","EKG","BK4588","GDOC","FFOX","LU0320765992.SGD","BK4585","HELX","GNOM","PTH","LU0109394709.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194764905","title":"Twinstrand勝訴：法院維持2023年故意侵權判決，並裁定Guardant Health 11項產品與服務須支付6%特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1194764905","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194764905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:01","pubTimestamp":1787569276,"startTime":"0","endTime":"0","summary":"法院裁定，维持2023年关于故意侵权的判决，同时要求Guardant Health公司就其11项产品及服务所产生的销售额，向Twinstrand支付6%的特许权使用费。这一裁决意味着，Twinstrand在知识产权纠纷中取得了关键性胜利。对于Guardant Health而言，这项决定无疑构成了财务上的重大负担。Twinstrand方面则对这一结果表示认可。此次6%特许权使用费的设定，亦反映了法院对此类行为的态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EKG","BK4585","BK4588","BK4535","LU0109394709.USD","GH","LU0320765992.SGD","GDOC","FFOX","GNMX","HELX","BK4551","GNOM","LU0889565916.HKD","PTH","BK4196","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127912643","title":"Twinstrand案判決：Guardant Health須按季度向公司及承銷商彙報11款產品與服務的全美銷售明細","url":"https://stock-news.laohu8.com/highlight/detail?id=1127912643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127912643?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"根据Twinstrand方面的消息，法院判决要求Guardant Health必须履行一项新的义务——按季度提交其在美国市场上全部11款产品与服务的销售账目，以供公司与承销商查阅。\n这一判决意味着，Guardant Health在运营透明度和合规性上将面临更为严格的监督。具体而言，公司需定期整理并呈报相关销售数据，确保各方能够及时掌握其业务动态。\n此举无疑为市场参与者提供了更清晰的视角，去审视这家精准医疗领域领军企业的真实业绩表现。季度汇报机制的建立，或将进一步影响投资者对该公司未来走势的评估与判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","LFSC","BK4196","BK4588","BK4535","LU0320765992.SGD","LU0109394709.USD","PTH","BK4551","GDOC","EKG","FFOX","GH","GNOM","HELX","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136746995","title":"Twinstrand：特拉華州法院於8月21日裁定公司及華盛頓大學在針對Guardant Health的專利侵權訴訟中勝訴","url":"https://stock-news.laohu8.com/highlight/detail?id=1136746995","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136746995?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"Twinstrand宣布，特拉华州法院已于8月21日作出判决，支持公司及华盛顿大学的立场，认定其在针对Guardant Health提起的专利侵权诉讼中占据优势。这一裁决标志着这场备受关注的法律纠纷取得了阶段性胜利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EKG","BK4585","BK4588","BK4535","LU0109394709.USD","GH","LU0320765992.SGD","GDOC","FFOX","GNMX","HELX","BK4551","GNOM","LU0889565916.HKD","PTH","BK4196","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661246882","title":"印度提議修改醫療器械規則。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661246882","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661246882?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 16:53","pubTimestamp":1787561605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","PTH","LNGR","IEIH","AGNG","MDEV","MEDX","HART","LGHT","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291662","title":"新產業：獲得血管緊張素轉化酶測定試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291662?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 15:56","pubTimestamp":1787558209,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","RSPH","MDEV","HART","LNGR","IEIH","PTH","AGNG","MEDX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661210916","title":"萬孚生物：取得7項化學發光類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2661210916","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661210916?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 16:14","pubTimestamp":1787472844,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","MDEV","AGNG","PTH","RSPH","HART","IEIH","LGHT","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661212103","title":"翔宇醫療激光毫米波治療儀獲國家醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2661212103","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661212103?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 08:00","pubTimestamp":1787443259,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","HART","LNGR","MDEV","PTH","GDOC","RSPH","LGHT","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661265431","title":"貴州公布13起典型案例","url":"https://stock-news.laohu8.com/highlight/detail?id=2661265431","media":"贵阳日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661265431?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 16:37","pubTimestamp":1787301420,"startTime":"0","endTime":"0","summary":"为发挥警示教育作用，现选取部分案例予以公布。经向备案机关核验，确认涉案备案凭证系伪造国家机关公文，当事人行为已涉嫌刑事犯罪。当事人案发后及时整改并完成退费，无同类处罚记录。依据《中华人民共和国消费者权益保护法实施条例》第五十条第一款规定，责令当事人改正违法行为，并处罚款的行政处罚。当事人共销售 7 盒涉案产品，货值","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-21/doc-inipakur8157728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IEIH","BK1583","RSPH","LGHT","BK1574","AGNG","GDOC","HART","PTH","MDEV","MEDX","09996","LNGR","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}